Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Xiaotong aerosol for acute lumbar sprain
ChiCTR1900026497Phase 2Not yet recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Mar 2019
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of xiaotong in lumbar sprain and musculoskeletal trauma (3 arms), sponsored by 中国中医科学院望京医院. Primary endpoint: Pain Visual Analog Scale score. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
xiaotong
03
Conditions
lumbar sprainmusculoskeletal trauma
Beyond the preview
Go deeper on ChiCTR1900026497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026497.